PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Oct-2024 CD Bioparticles Introduces New Line of NIST Traceable Polystyrene Particle Size Standards CD Bioparticles
25-Oct-2024 CD BioSciences Launches Innovative Immune System Tissue Microarrays for Research Usage CD BioSciences
25-Oct-2024 STEMart Introduces Advanced Accelerated Aging Testing Services for Medical Devices STEMart
25-Oct-2024 Creative Diagnostics Releases Yeast DNA Residue Assay Kits (qPCR) for Biological Research Creative Diagnostics
25-Oct-2024 Creative Diagnostics Announces New Zearalenone Test Reagents for Food Safety Applications Creative Diagnostics
25-Oct-2024 Creative Diagnostics Launches Advanced Influenza A Virus Mouse Models for Accelerated Research Creative Diagnostics
25-Oct-2024 H5N1 Antibodies and Antigens for Research Applications Creative Diagnostics
24-Oct-2024 Oxford Medical Products Debuts Promising Results from First Randomised Controlled Trial (RCT) of Sirona: A Revolutionary Non-Pharmacological Weight-Loss Treatment Oxford Medical Products Ltd
23-Oct-2024 Watson-Marlow Fluid Technology Solutions to showcase peristaltic filling machines and new single-use solutions at PACK EXPO International 2024 Watson-Marlow Fluid Technology Group
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech SynaptixBio
23-Oct-2024 ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares ProQR Therapeutics
23-Oct-2024 4Tissue Raises €2M to Advance Groundbreaking Breast Tissue Replacement Technology 4Tissue
23-Oct-2024 Capital Markets Event 2024: Lundbeck to showcase progress on Focused Innovator Strategy driving sustainable long-term growth H. Lundbeck A/S
23-Oct-2024 DARZALEX® (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible Janssen-Cilag International NV
23-Oct-2024 Senzime secures first European hospital order for its new next-generation TetraGraph system Senzime
23-Oct-2024 Biocartis announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting Biocartis NV
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics
23-Oct-2024 OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OKYO Pharma Limited
23-Oct-2024 Duhn Therapeutics, launched by Landmark BioVentures, signs global license agreement with OM Pharma to further advance clinical-stage, lipid-based cancer immunotherapy Andrew Lloyd Associates
23-Oct-2024 AMYRA Successfully Demonstrates a New Therapeutic Paradigm for Gluten-Related Disorders in a First-in-Human Study AMYRA Biotech